Casting Techniques for Elbow Fractures
Trial Summary
What is the purpose of this trial?
This study compares the clinical outcomes of treating pediatric Type 1 supracondylar fracture with a long arm soft cast and no clinical or radiographic follow-up versus the standard treatment in a long arm cast with clinical follow-up. This is the first multicenter randomized control trial looking at the clinical effectiveness, safety and parental satisfaction of managing inherently stable Type I supracondylar fractures without clinical or radiological follow-up. If found to be safe; children can be managed effectively without in-person follow-up, freeing clinic appointments to children on the waiting list and in these COVID times avoiding unnecessary contacts.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Long arm full cast and Long arm soft cast for elbow fractures?
Is casting for elbow fractures generally safe in humans?
How does the long arm soft cast treatment differ from other treatments for elbow fractures?
The long arm soft cast is unique because it is made from a semirigid material that combines fiberglass and polyurethane resin, allowing for a removable and potentially more comfortable option compared to traditional hard casts. This treatment is particularly useful for nondisplaced pediatric elbow fractures, offering similar outcomes to hard casts while being easier to manage.12101112
Eligibility Criteria
This trial is for children aged 3 to 8 with a specific type of elbow fracture (Type 1 supracondylar humerus fracture) that doesn't involve bone displacement. Kids must have symptoms like arm tenderness, swelling, and certain signs on an X-ray. Those with nerve/blood vessel damage, bone diseases, or more severe fractures are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a long arm cast, with Group 1 receiving routine follow-up and Group 2 receiving no clinical or radiographic follow-up
Follow-up
Participants are monitored for safety and effectiveness after treatment via surveys and photographs
Treatment Details
Interventions
- Long arm full cast
- Long arm soft cast
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Queensland Children's Hospital, South Brisbane
Collaborator